Paediatrics

Positive findings in a gene therapy trial for patients with Leber Congenital Amaurosis Type 5.

Dr. Quan Dong Nguyen presents interim data from the phase 3 DRAGON study on a potential first therapy for adolescent Stargardt disease.

Explore the challenges and insights in long-term follow-up of paediatric gene therapy, focusing on data integrity, patient retention, and ethical considerations.

Prof Dr Rajvardhan Azad explains how unified guidelines, AI-driven tools, and cross-disciplinary collaboration could transform outcomes for premature infants.

Dr. J. Peter Campbell discusses the technologies shaping retinopathy of prematurity detection, clinical integration, and global implementation.

While the FDA requests additional evidence of efficacy for the low-dose atropine eye drop in the US, the formulation has already gained European Commission approval as Ryjunea for slowing paediatric myopia progression.

A pair of studies, conducted in Taiwan and China, indicate that red light therapy could serve as an effective and safe alternative to atropine

Salvation of ocular tissues and visual acuity are dependent on early diagnosis, investigators emphasised

An ophthalmologic examination revealed bilateral anterior uveitis, though the patient had no ocular complaints at presentation

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a mitochondrial disease treatment

Enhanced screenings and a unified registry could save vision and lives

The SYD-101 atropine formulation is licensed by Santen SA, based in Switzerland, from Sydnexis Inc, based in California

The researchers shared the first cohort study established in China that examines the relationship between secondhand smoke and early onset of myopia

The global prevalence of myopia has surged, and is expected to affect nearly 5 billion people by 2050

Dinah Zur, MD, shares insights from her International SPECTRALIS Symposium lecture

The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

Paediatric diagnoses of juvenile idiopathic intracranial hypertension, optic neuritis and Horner syndrome

According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.

Social media smartphone application–based interventions significantly improved adherence and parental knowledge among families of children with congenital ectopia lentis

Ophthalmologists report that dry eye syndrome, myopia progression and other ocular pathologies have increased, especially among paediatric patient groups

The study findings support the need to consider ophthalmologic monitoring in children with early-onset atopic dermatitis

How studies into myopia management can increase access to vision care

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

The study assessed a large paediatric cohort for changes in spherical equivalent refraction, axial length, lens power and lens thickness